<DOC>
	<DOCNO>NCT01812148</DOCNO>
	<brief_summary>Review investigator hospital experience cytoreductive surgery hyperthermic intra-peritoneal chemotherapy ( HIPEC ) peritoneal mesothelioma , use Oxaliplatin intraperitoneal chemotherapeutic agent .</brief_summary>
	<brief_title>Survival Peritoneal Mesothelioma After Cytoreductive Surgery Hyperthermic Intra-peritoneal Chemotherapy ( HIPEC )</brief_title>
	<detailed_description>Observation primary outcome : - Overall Survival - Disease-free survival Influencing factor observe : - Sex - Blood loss - Time surgery - Number resection anastomosis - Peritoneal Index ( PI score ) - Cytoreductibility ( CCR score )</detailed_description>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Peritoneal mesothelioma Non resectable disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Peritoneal Mesotheliomas</keyword>
	<keyword>hyperthermic intra-peritoneal chemotherapy ( HIPEC )</keyword>
	<keyword>Oxaliplatin</keyword>
	<keyword>Cytoreductive surgery</keyword>
	<keyword>Oxaliplatin HIPEC</keyword>
</DOC>